Article: Imitrex(R) (Sumatriptan Succinate) Tablets Now Available in an Innovative Formulation For Migraine Sufferers; New Formulation Designed to Rapidly Release in the Stomach*.

RESEARCH TRIANGLE PARK, N.C., Feb. 4 /PRNewswire/ -- Today, GlaxoSmithKline announced the availability of new Imitrex(R) tablets, a novel formulation of GSK's leading migraine therapy. The new formulation contains the same active ingredient with the same proven efficacy and safety profile of the conventional Imitrex tablets now with an innovative technology for rapid disintegration of the product in the stomach.

The rapid-release technology of new Imitrex tablets works differently from oral disintegrating tablets, also known as oral melts, which dissolve on the tongue. New Imitrex tablets, which replace the old tablets, are swallowed whole with water like ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!